MG
AORT icon

Marex Group’s Artivion AORT Stock Holding History

Marex Group’s Portfolio AORT Stock Details AORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,000
Closed -$659K – 1131
2026
Q1 		$659K Buy
+18,000
New +$710K ﹤0.01% 547

Other funds holding AORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Marex Group's AORT Position: Q2 2026 in Review

Marex Group sold out of Artivion (AORT) in Q2 2026, closing a stake of 18,000 shares — an estimated $659K sold.

Marex Group first reported a position in AORT in Q1 2026 and held it in 1 quarter. The position peaked at $659K in Q1 2026. 207 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • Marex Group reported no remaining Artivion position as of Q2 2026 after selling out during the quarter.
  • Marex Group sold 18,000 Artivion shares in Q2 2026, an estimated $659K.
  • Marex Group first reported a position in Artivion in Q1 2026 and held it in 1 quarter.
  • Marex Group's Artivion position peaked at $659K in Q1 2026.
  • 207 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.